Concepedia

Philipp Müller

PM

Statistics

Publications

33

Citations

2K

H-Index

21

Active since

1982

Affiliations

Novartis (Switzerland)(Current)

Tampere University

University of Bern

Institute of Social and Preventive Medicine

Philipp Müller is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1982–2023

33

Publications

33

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure

Wolfgang Kiowski, J Kim, Erwin Oechslin et al. · The Lancet · 1995 · 573 citations

, , +7

CONTROLLED TRIAL OF TRANSDERMAL NICOTINE PATCH IN TOBACCO WITHDRAWAL

T Abelin, Philipp Müller, Adrian Büehler et al. · The Lancet · 1989 · 201 citations

, , +9

Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man

Gérard Flesch, Philipp Müller, Peter Lloyd · European Journal of Clinical Pharmacology · 1997 · 199 citations

, , +5

Human pharmacological studies of a new transdermal system containing nitroglycerin

Philipp Müller, P Imhof, F Burkart et al. · European Journal of Clinical Pharmacology · 1982 · 140 citations

, , +3

Effectiveness of a transdermal nicotine system in smoking cessation studies.

T Abelin, Rolf Ehrsam, A Bühler-Reichert et al. · PubMed · 1989 · 77 citations

, , +15

1–5 of 33